Advanced search
Publication Cover
Current Medical Research and Opinion Volume 13, 1997 - Issue 10
Submit an article Journal homepage
63
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Controlled clinical trial on the efficacy and safety of oral sulodexide in patients with peripheral occlusive arterial disease

S. B. Shustov Faculty of Endocrinology, Military Medical Academy, St Petersburg, Russia
&
Dr Nadia Canova Faculty of Endocrinology, Military Medical Academy, St Petersburg, Russia
Pages 573-582 | Accepted 15 Mar 1997, Published online: 12 Aug 2008

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sergio Coccheri & Ferdinando Mannello. (2014) Development and use of sulodexide in vascular diseases: implications for treatment. Drug Design, Development and Therapy 8, pages 49-65.
Read now
J Lasierra-Cirujeda, P Coronel, MJ Aza & M Gimeno. (2010) Use of sulodexide in patients with peripheral vascular disease. Journal of Blood Medicine 1, pages 105-114.
Read now

Articles from other publishers (8)

Angelo A. Bignamini, Ahmed Chebil, Giovanni Gambaro & Jiří Matuška. (2021) Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis. Advances in Therapy 38:3, pages 1483-1513.
Crossref
Cathryn Broderick, Rachel Forster, Mohammed Abdel-Hadi & Kareem Salhiyyah. (2020) Pentoxifylline for intermittent claudication. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Antonio Vittorino Gaddi, Fabio Capello, Oana Florentina Gheorghe-Fronea, Simone Fadda & Roxana Oana Darabont. (2020) Sulodexide improves pain-free walking distance in patients with lower extremity peripheral arterial disease: A systematic review and meta-analysis. JRSM Cardiovascular Disease 9, pages 204800402090700.
Crossref
Kareem Salhiyyah, Rachel Forster, Eshan Senanayake, Mohammed Abdel-Hadi, Andrew Booth & Jonathan A Michaels. (2015) Pentoxifylline for intermittent claudication. Cochrane Database of Systematic Reviews.
Crossref
Zhihua Zheng. (2013) Sulodexide may alleviate neointimal hyperplasia by inhibiting angiopoietin‑2 in an arteriovenous fistula model. Molecular Medicine Reports.
Crossref
Kareem Salhiyyah, Eshan Senanayake, Mohammed Abdel-Hadi, Andrew Booth & Jonathan A Michaels. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Phyu Phyu Aung, Heather Maxwell, Ruth G Jepson, Jackie Price & Gillian C Leng. (2007) Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database of Systematic Reviews.
Crossref
B. M. Errichi, M. R. Cesarone, G. Belcaro, R. Marinucci, A. Ricci, A. Ippolito, R. Brandolini, G. Vinciguerra, M. Dugall, A. Felicita, L. Pellegrini, G. Gizzi, M. Ruffini, G. Acerbi, P. Bavera, A. Di Renzo, M. Corsi, M. Scoccianti, M. Hosoi & M. Lania. (2016) Prevention of Recurrent Deep Venous Thrombosis with Sulodexide: The SanVal Registry. Angiology 55:3, pages 243-249.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.